Whether you are trying to understand where your brand and competitors fit in the real-world patient journey, how patients are being referred within local networks and Key Accounts, how patients are switching between therapies and what the switching drivers are, who the emerging clinical trial patients are, who the emerging new patients for your brand are, how to improve 60-day patient hub starts, which patients are likely to be non-compliant or discontinue therapy, how your brand’s patient outcome compares with competitors, where to play or how to win, or summarize insights about patient treatment patterns for your targets leveraging GenAI, the TWIG team can help you with your questions.
We will partner with your team as you aim to expand patient share and improve patient outcome by unlocking compelling business insights and recommending targeted actions by integrating patient data, visualizing patient treatment journey across lines of therapy and specialists, mapping patient referral pathways, identifying KOLs, and finding emerging clinical trial patients, as well as new, non-compliant and discontinuing patients utilizing AI / Machine Learning and GenAI techniques.
